glp-1 cardiovascular outcomes news today medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major GLP-1 Receptor Agonists for the

They also include different formulations, delivery devices, and combinations with other drugs

This provided more evidence that miR-34a plays a role in the GLP-1 mechanism that regulates the proliferation and survival of beta cells [177]

However, others showed that daily administration of a peptide antagonist for one week enhanced weight gain and food intake in diet-induced obese mice (95)

Oral semaglutide offers a familiar molecule in pill form, with meaningful efficacy and cardiovascular data from the SELECT trial

However, these patches were medical-grade formulations and are not comparable to commercially available over the counter supplement patches